Chengdu-based Clover Biopharmaceuticals has raised $230 million in Series C funding led by GL Ventures and Temasek Holdings. Oceanpine Capital, OrbiMed, and Delos Capital all re-upped.
The company claims to have received more than $400 million in funding over the past 12 months. Its Series B round - worth $43 million - was announced in 2019. Lapam Capital and Delos were the lead investors....
Fiture, a Chinese developer of artificial intelligence-enabled home fitness devices, has raised $300 million in Series B funding led by All-Stars Investment, Legend Capital, DST Global, and Coatue Management.
Arrail Group, one of China’s largest dental services providers, has raised close to $200 million in Series E funding led by Temasek Holdings.
TuSimple, a China and US-based developer of autonomous driving technology for trucks, traded flat on debut following a $1.35 billion IPO at a market capitalization of $8.5 billion.
Alpha JWC Ventures is targeting $250 million for its third Indonesia-focused venture capital fund, with the International Finance Corporation (IFC) proposing a commitment of up to $20 million.